69 related articles for article (PubMed ID: 24088132)
21. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
[TBL] [Abstract][Full Text] [Related]
22. The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.
Liao LH; Zhang H; Lai MP; Lau KW; Lai AK; Zhang JH; Wang Q; Wei W; Chai JH; Lung ML; Tai SS; Wu M
Clin Chim Acta; 2007 May; 380(1-2):191-6. PubMed ID: 17368604
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
24. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Sébille V; Colman H; Le Houérou C; Le Neel T; Bourdon J; Faroux R; Ollivry J; Lafraise B; Chupin LD; Bézieau S
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1460-7. PubMed ID: 17627011
[TBL] [Abstract][Full Text] [Related]
25. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
27. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
28. Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients.
VAN Nguyen S; Skarstedt M; Löfgren S; Zar N; Andersson RE; Lindh M; Matussek A; Dimberg J
Anticancer Res; 2013 Aug; 33(8):3247-50. PubMed ID: 23898086
[TBL] [Abstract][Full Text] [Related]
29. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
30. MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations.
Gao J; Arbman G; He L; Qiao F; Zhang Z; Zhao Z; Rosell J; Sun XF
Acta Oncol; 2008; 47(3):372-8. PubMed ID: 17899454
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
Viet HT; Wågsäter D; Hugander A; Dimberg J
Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
[TBL] [Abstract][Full Text] [Related]
32. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
33. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.
Aiyappa-Maudsley R; Storr SJ; Rakha EA; Green AR; Ellis IO; Martin SG
J Pathol Clin Res; 2022 Nov; 8(6):550-566. PubMed ID: 35902379
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor 1 (PAI-1) 1334G/A genetic polymorphism in colorectal cancer.
Smolarz B; Romanowicz-Makowska H; Kulig A
Acta Biochim Pol; 2003; 50(2):489-95. PubMed ID: 12833173
[TBL] [Abstract][Full Text] [Related]
35. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
36. Granzyme B gene polymorphisms, colorectal cancer risk, and metastasis.
Mhaidat NM; Al-azzam SI; Alzoubi KH; Khabour OF; Gharaibeh BF
J Cancer Res Ther; 2014; 10(3):587-90. PubMed ID: 25313744
[TBL] [Abstract][Full Text] [Related]
37. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
38. Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapy.
Karlgren M; Ingelman-Sundberg M
Expert Opin Ther Targets; 2007 Jan; 11(1):61-7. PubMed ID: 17150034
[TBL] [Abstract][Full Text] [Related]
39. Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates.
Zhao Y; Wan D; Yang J; Hammock BD; Ortiz de Montellano PR
Drug Metab Dispos; 2016 May; 44(5):771-80. PubMed ID: 26936974
[TBL] [Abstract][Full Text] [Related]
40. Bioactivation of Aromatic Amines by Human CYP2W1, An Orphan Cytochrome P450 Enzyme.
Eun CY; Han S; Lim YR; Park HG; Han JS; Cho KS; Chun YJ; Kim D
Toxicol Res; 2010 Sep; 26(3):171-5. PubMed ID: 24278521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
